J&J will de­fend its pro­posed 340B changes as US threat­ens penal­ties

The US’ Health Re­sources and Ser­vices Ad­min­is­tra­tion threat­ened John­son & John­son with fines for uni­lat­er­al­ly re­shap­ing the com­pa­ny’s in­volve­ment in the multi­bil­lion-dol­lar fed­er­al drug dis­count …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER